Certainly corporate debt may be seen as less risky than equities, or even government debt (depending on the government, though I notice US Treasuries have gone up since the S&P announcement). But this really depends on the company, and Alchemia is hardly IBM or Microsoft.
I think some kind of convertible note is most likely, but that's likely to be just a diluting as a capital raising.
what a bargain, page-13
Add TSN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| TSN (ASX) Chart |
Day chart unavailable